ExonHit Licenses Array-Based Toxicity Ranking System to Mitsubishi Pharma | GenomeWeb

NEW YORK, Sept. 15 (GenomeWeb News) - ExonHit Therapeutics has licensed its microarray-based toxicity evaluation system, Safe-Hit, to Mitsubishi Pharma, the Paris-based company said today.


Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

Sequencing of a 10,000-year-old mummy leads to its repatriation to the Fallon Paiute-Shoshone Tribe, Nature News reports.

The final text of the bill to reauthorize the America COMPETES Act might smooth over the differences between NSF and the House science committee, ScienceInsider says.

Four Republican lawmakers urge President-elect Donald Trump to keep Francis Collins as NIH director, Stat News reports.

In Genome Research this week: Platinum variant catalog, algorithmic strategy for upgrading fragmented assemblies, and more.